Neurology

Fierce Pharma

Ionis scores ‘breakthrough’ rare disease approval

The FDA has approved Ionis' Zanvastro, the first medicine for Alexander disease and a first step in Ionis' journey to building a solo neuro franchise.

Darren Incorvaia Sep 4, 2026 11:18am

CNS Pharma wipes glioblastoma pipeline clean in strategic pivot

Mar 11, 2026 10:30am

Naox nabs 1st FDA clearance for in-ear EEG device

Jan 6, 2026 9:25am

Businesspeople walking towards a bright light at the end of a white corridor

NIH instability grows with exit of longtime neuro director

Jan 2, 2026 2:16pm

AstraZeneca drops MASH drug over disappointing data

Nov 6, 2025 5:21am

Lilly saves gene therapy biotech with $18M upfront deal

Apr 3, 2025 6:00pm